News-Morimatsu LifeSciences

FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION

BACK

WuXi XDC's Singapore Site Achieves GMP Release, with Pharmadule Morimatsu Supporting Its Global Bioconjugate Expansion

On September 21, 2026, WuXi XDC held a release ceremony for its Singapore manufacturing site at the Tuas Biomedical Park in Singapore. As a cornerstone of WuXi XDC's commercial manufacturing network, the BCM3 antibody intermediate and conjugated drug substance dual-function production line and t
Morimatsu’s End-to-End Manufacturing of Single-Use Consumables: Building Robust, Compliant Process Solutions

In biopharmaceutical manufacturing, single-use systems have become an integral part of processes ranging from R&D to commercial production, thanks to their flexibility, reduced risk of cross-contamination, and lower validation requirements. The quality of single-use consumables can directly affe
Invitation Letter | Morimatsu Invites You to Join Us at farmaforum 2026

📌 We‘re heading to Farmaforum at IFEMA Madrid, one of the most important trade fairs for the pharmaceutical, cosmetics, and analytical laboratory industries.📅 Date: 22-23 September, 2026📍 Venue: IFEMA Madrid,Spain🎯 Booth: I6Visit us to explore new technologies and see how our latest solutio
Invitation Letter | Morimatsu Invites You to Join Us at SBJ Annual Meeting

✨ We‘re thrilled to announce that we will be exhibiting at the 78th Annual Meeting of the Society for Biotechnology, Japan (SBJ)！📅 Date: 15-17 September, 2026📍 Venue: Hokkaido University, Sapporo Campus, Japan🎯 Booth: 48🔍 Join our team to discover the latest innovations, exploring Total B
Morimatsu Joins BioPIPS to Build an Innovation Hub for Asia-Pacific Biopharma

Recently, Morimatsu officially joined the Biologics Pharma Innovation Programme Singapore (BioPIPS). This milestone marks Morimatsu’s deep integration into the global top-tier biopharma innovation ecosystem. It will further expand the company’s capabilities in biopharmaceutical manufacturing, driv

Prev 1 2 3 4 5··· Next